CAR-T cell therapiesTocilizumabCRSuniversity hospitalmultiorgan failure
…ty hospital is involved as a sponsor of clinical trials on both CAR-T cell therapies and bispecific antibodies (BsAbs), actively contributing to the…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 2,101–2,160 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
CREST-21CRS-HIPEC1CSAI1CSD1CSIs1CT1CT angiography1CT-guided percutaneous fibrin glue embolization1CTs1CVVHDF1CYP2C19-guided antiplatelet therapy1Casting1Cervical anesthetic blocks1Cervical epidural steroid injections1Cervical retrolaminar blocks1Cesarean section1Checkpoint inhibitor immunotherapy1Childhood cancer treatment1Chimeric Antigen Receptor (CAR) T cell therapies1Chimeric Antigen Receptor T (CAR T) cell therapies1Chimeric Antigen Receptor T cell therapy1Chimeric antigen receptor (CAR) T -cell therapy1Chimeric antigen receptor (CAR) T therapies1Chimeric antigen receptor (CAR) T therapy1Chimeric antigen receptor (CAR) T treatments1Chimeric antigen receptor (CAR) therapies1Chimeric antigen receptor T (CAR-T) cell therapies1Chimeric antigen receptor natural killer cell (CAR-NK) therapy1Chinese herbal medicine1Chronic pain management1Chuna manual therapy1Chuna therapy1Claudin 18.2-directed therapies1Claudin18.2-specific CAR-T cell therapy1Cognitive remediation therapy1Coil-adjunct embolization1Combined chemoradiotherapy1Compassionate care1Complete revascularisation1Concussion Essentials1Contraceptive technology1Contragestion1Conventional Therapy1Conventional immunosuppressants1Conventional opioid therapy1Corneal endothelial cell therapy1Coronary sinus reducer (CSR) implantation1Corticosteroid re-escalation1Corticosteroids in palliative care1Cranioplasty1Cryoballoon Focal Ablation1Cryoballoon ablation1Curative-intent multimodality treatment1D3 right extended hemicolectomy1DA-EPOCH polychemotherapy1DAE1DAsC-assisted aspiration thrombectomy1DCBA1DCCV1DCE1
Articles mentioning treatments
7,227 articles · page 390 of 603CAR-T cell therapyTocilizumabhaematologic malignanciesuniversity hospitalCRScorticosteroidscytokine release syndromemultiorgan failure
…strate the central role we play in this therapeutic innovation. CAR-T cell therapy is a major breakthrough in the management of haematologic malig…
ketogenic dietAicardi syndromevigabatrinperampanellevetiracetamhydrocortisonelamotriginefenfluraminevalproic acidtopiramate+2 more
…motrigine, valproic acid, vigabatrin, levetiracetam, primidone, ketogenic diet, rufinamide, topiramate, zonisamide, perampanel, and hydrocorti…
therapeutic anticoagulationaspirinVTEhaemorrhagecerebral accidents
…drug chart and administered at the correct time. With regard to therapeutic anticoagulation, statistical significance was found in the documentation of ind…
Oncology treatmentenzalutamideapalutamidepazopanibabirateroneolaparibsunitinibcapecitabineimatinibosimertinib+8 more
…Background and Importance Oncology treatment requires continuous monitoring and appropriate pharmacotherapeu…
Chimeric Antigen Receptor T-cell (CAR-T) therapyaxicabtagene ciloleuceltisagenlecleucelciltacabtagene autoleucelmultiple myelomaDLBCLanakinraacute lymphoblastic leukaemiadiffuse large B-cell lymphomaICANS+1 more
…Background and Importance Chimeric Antigen Receptor T-cell (CAR-T) therapy has improved outcomes in relapsed or refractory haematological …
Combination therapylinezolidceftazidime-avibactamcolistinoxazolidinonesnosocomial infectionsurinary tract infectionsmultidrug-resistant infections
…inly for respiratory (21.9%) and urinary tract infections (8%). Combination therapy was used in 26.7% of prescriptions, mainly for synergistic purp…
Immune checkpoint inhibitorspembrolizumabtertiary hospitalNSCLCmetastatic non-small-cell lung adenocarcinomaproton pump inhibitors
…Background and Importance Immune checkpoint inhibitors (ICI) have become a standard treatment in multiple malignancies…
DAPTaspiriniP2Y12chronic kidney diseaseacute myocardial infarctionatrial fibrillationdiabetes mellitustertiary hospitalNon-ST-segment Elevation Myocardial InfarctionST-segment elevation myocardial infarction+5 more
…in discharge treatment between men and women were observed (eg, DAPT and anticoagulation), these were not statistically significant.…
Therapeutic drug monitoringlinezolidamiodaroneclarithromycinamlodipinesevere infectionslevothyroxineRifampicinphenobarbital
…acokinetic variability may compromise both efficacy and safety. Therapeutic drug monitoring (TDM) can optimise dosing and reduce the risk of adverse effect…
CAR T-cell therapyECOG Performance StatusTisagenlecleucelKymriahhematologic malignanciesTecartusbrexucabtagén autoleucelYescartaAxicabtagén ciloleucelmantle cell lymphoma+5 more
…pitalisation was 23.5 days (IQR 17-28).Conclusion and Relevance CAR T-cell therapy in real-world-practice achieves high early response rates, alth…
corticosteroid therapyipilimumablevofloxacinnivolumabprednisoneipilimumab/nivolumabamoxicillin–clavulanatelevetiracetamadvanced clear-cell renal carcinoma
…diated origin of hepatic and neurological alterations optimised corticosteroid therapy and improved patient safety.Material and Methods Ipilimumab/niv…